Track and Trace for Pharma Exports Postponed by One Year to 1 April 2023

[Public Notice No. 01/2015-20 Dated 4 April 2022

Effect of this Public Notice: The date for implementation of Track and Trace system for export of drug formulations with respect to maintaining the Parent-Child relationship in packaging levels and its uploading on Central Portal has been extended upto 31.3.2023 for both SSI and non SSI manufactured drugs.

Subject: Implementation of the Track and Trace system for export of Pharmaceuticals and drug consignments along with maintaining the Parent-Child relationship in the levels of packaging and their movement in supply chain - Extension of date of implementation.

In exercise of the powers conferred under Paragraph 2.04 of the Foreign Trade Policy, 2015-20, as amended from time to time, the Director General of Foreign 'Trade hereby amends Para 2.90 A of Handbook of Procedure- 2015-20, as notified vide Public Notice No. 43/2015-20 dated 05.12,2017 read with Public Notice No. 52 I 2015-20 dated 05.01.2016, Public Notice No. 05/2015-20 dated 09.05.2018, Public Notice No. 43/2015- 2020 dated 01 .11 .2018, Public Notice No. 16/2015- 2020 dated 04.07.2019, Public Notice No. 66/2015-2020 dated 30.03.2020, Public Notice No. 16/2015-2020 dated 22.9.2020 and Public Notice No. 46/2015-20 dated 30.03.2021 on laying down the procedure for implementation of the Track and Trace system for export consignments of drug formulations.

2. In Para 2.90 A (vi) and (vii) of Handbook of Procedure- 2015-20 (as amended vide Public Notice No. 46/2015-20 dated 30.03.2021), "01.04.2022" may be substituted by "31.3.2023".

(Issued from F. No. 01/911180/648/AM-09/EC/E-21052)